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Background: Conflicting findings from studies evaluating associations of allergic disease 
with child behaviour require longitudinal studies to resolve. 
Objective: To estimate the magnitude of associations of atopic dermatitis (AD) in infancy, 
and symptoms of asthma and AD at 6.5 years, with child behaviour at 6.5 years. 
Methods: Secondary cohort analysis of the PROmotion of Breastfeeding Intervention Trial 
(PROBIT). PROBIT enrolled 17,046 infants at birth and followed them up at 6.5 years 
(n=13,889). Study paediatricians collected data on infantile AD at repeated follow-up 
examinations during the first year of life. At 6.5 years paediatricians performed skin prick 
tests and parents reported asthma and AD symptoms during the prior year.  In addition, 
parents and teachers completed the Strength and Difficulties Questionnaire, which includes 
scales on hyperactivity/inattention, emotional problems, conduct problems, peer problems and 
prosocial behaviours. 
Results: Physician-diagnosed AD in the first year of life was not associated with increased 
risk for behavioural problems at 6.5 years. Emotional problems at 6.5 years were more 
common among children with AD symptoms (OR: 2.24, 95% CI 1.62-3.12) and asthma 
symptoms (OR: 1.45; 95% CI, 1.07-1.96) during the past year at 6.5 years and ORs for 
children with symptoms of more severe AD and asthma were also higher. AD in the past year 
was also associated with probable hyperactivity/inattention disorder at 6.5 years (OR: 2.05; 
95% CI, 1.09-3.84). Other subscales of the SDQ were not related to asthma or AD symptoms 
during the past year. 
Conclusions and clinical relevance: Children with AD symptoms were at higher risk for 




symptoms were at higher risk of having concomitant emotional problems. However, AD 
during infancy did not predict childhood behaviours.  
Abbreviations 
AD: atopic dermatitis 
ADHD: attention deficit/hyperactivity disorder  
CI: confidence intervals 
OR: odds ratio  







Atopic dermatitis (AD, syn. ‘atopic eczema’(1)) and asthma are common chronic diseases in 
childhood. A number of studies have reported associations of allergic diseases with attention 
deficit hyperactivity disorder (ADHD) and other behavioural problems in childhood.(2-
22)However, many of these studies were retrospective in design (2-8, 11, 13, 18, 19), with 
recalled ascertainment of exposure data after diagnosis, and so are inherently vulnerable to 
recall and reverse causation biases.(23) Other cross-sectional studies have not observed an 
association between allergic diseases and behaviour.(24-26) 
Longitudinal cohorts include prospectively collected data on background factors and potential 
confounders and allow stronger causal inference, based on the temporal sequence between 
exposure and outcome. Findings from longitudinal studies evaluating allergic diseases in 
relation to child behaviour are inconsistent.(27-31) In longitudinal studies from Germany, AD 
early in life was associated with conduct problems, emotional problems, and ADHD at school 
age(28, 29), while no association was found between AD and ADHD in a larger birth cohort 
including 3,000 Swedish children.(30)  In the British ALSPAC birth cohort, child behaviour 
was reported by teachers for a subpopulation (n=4,366) at age 8 years; late-onset AD was 
associated with a higher risk of internalizing behaviours (emotional problems and peer 
problems), persistent rash increased the risk for externalizing behaviours (conduct problems 
and hyperactivity/inattention), while no association was observed between wheeze and 
behaviour.(31)  In contrast, a birth cohort study from the US in 546 newborns at risk of 
developing allergic diseases found that wheezing at age 4 years was associated with 





Several potential pathways have been suggested to explain the associations between atopic 
diseases and child behaviour, including: i) shared genetic vulnerability; ii) behavioural 
consequences of chronic symptoms; iii) a neuro-immunologic pathway in which the release of 
pro-inflammatory mediators early in life (due to an atopic disease) affects brain maturation 
and leads to behaviour problems; and iv) disturbed sleep due to atopic diseases, in particular 
the intense itching associated with AD, may cause subsequent behavioural problems.(23, 27)  
The PROBIT cohort (n=17,046) provides an opportunity to prospectively study the 
relationship of physician diagnosed infantile AD with behavioural problems at 6.5 years and 
the cross-sectional relationship between AD and asthma symptoms with behavioural problems 
at 6.5 years. We undertook a secondary (observational) analysis to estimate the magnitude of 
these associations. We hypothesized that AD in infancy and also AD or asthma symptoms 




MATERIAL AND METHODS 
Study design and study subjects 
PROBIT is a cluster-randomized controlled trial (ISRCTN37687716) of a breastfeeding 
promotion intervention set in the Republic of Belarus.(32) Maternity hospitals and one each 
of their affiliated polyclinics were randomly assigned to receive the intervention based on the 
Baby-Friendly Hospital Initiative (intervention group) or to continue the prevailing maternity 
hospital and polyclinic practices at the time of randomization (control group). A total of 
17,046 mothers and their healthy, full-term singleton infants born between June 1996 and 
December 1997 were recruited during their post-partum stay in 31 maternity hospitals and 
followed-up in infancy and childhood at affiliated polyclinics. At recruitment, information on 
background characteristics was collected.  
Mother-infant pairs were followed up at 1, 2, 3, 6, 9 and 12 months of age, including regular 
paediatrician-conducted skin examinations of all participants. Additional follow-up was 
carried out 2002-2005, when the children were aged 6.5 years. The accompanying parent 
(usually the mother) answered questions on allergic symptoms contained in the International 
Study for Asthma and Allergies in Childhood (ISAAC) questionnaire(33), as well as other 
questions. In addition, both a parent and the child’s teacher evaluated the child’s behaviour 
using the Strength and Difficulties Questionnaire (SDQ).(34) Finally, study paediatricians 
administered skin prick tests (SPTs) for five inhalant allergens at the 6.5-year visit.(35) 
PROBIT was approved by the Belarusian Ministry of Health and received ethical approval 
from the McGill University Health Centre research ethics board, the institutional review 
board at Harvard Pilgrim Health Care, and the Avon Longitudinal Study of Parents and 
Children Law and Ethics Committee. A parent or legal guardian provided written informed 





Exposures and outcomes  
AD assessments based on skin examinations in infancy (PROBIT Phase I) 
Participants were categorized as having infantile AD if they had rashes that lasted at least two 
weeks or recurred after clearing for at least one week, were itchy and occurred on the face 
and/or the extensor surfaces of the arms and/or on the extensor surfaces of the legs. 
Participants with infantile AD that was present at two or more follow-up visits and that 
affected two or more body sites were categorized as having ‘severe’ infantile AD.   
SPTs, AD and asthma symptoms in the past year at 6.5 (PROBIT Phase II) 
Skin-prick tests were performed with inhalant allergens (Allergy Canada) to house dust mite, 
cat dander, birch pollen, mixed northern grasses, and Alternaria.(35) The accompanying 
parent completed the International Study for Asthma and Allergies in Childhood (ISAAC) 
questionnaire which included a series of yes or no questions about asthma and AD 
symptoms.(36) The question on asthma symptoms in the previous year was: “Has your child 
had wheezing or whistling in your chest at any time in the last 12 months?” (‘wheeze past 
year’). For assessment of severe asthma the questionnaire asked: “How many attacks of 
wheezing has your child had in the last 12 months?”, “In the past 12 months, on average, has 
your child’s sleep been disturbed due to wheezing?” and “In the past 12 months, has 
wheezing ever been severe enough to limit your child's speech to only one or two words at a 
time between breaths?” We used the ISAAC definition of severe asthma: 4 or more attacks of 
wheeze or 1 or more nights per week sleep disturbance from wheeze or wheeze affecting 
speech in the past 12 months.(37) For AD symptoms, the questionnaire asked: “Has your 
child ever had an itchy rash which was coming and going for at least six months?”, “Has your 
child had this itchy rash at any time in the past 12 months?” (‘AD symptoms past year’), and 




behind the knees, in front of the ankles, around the neck, or eyes?” (‘flexural AD past year’). 
AD severity was assessed by the questions “Has this rash cleared completely at any time 
during the past 12 months?” and “In the past 12 months, how often, on average, has your 
child been kept awake at night by this itchy rash?” (‘never in the past 12 months’/‘less than 
one night per week’/‘one or more nights per week’).  
Behaviour assessments at 6.5 years (PROBIT Phase II) 
We used the Strength and Difficulties Questionnaire (SDQ), a validated screening tool, 
designed to detect behavioural strengths and difficulties of children 4 to16 years of age.(34) 
The SDQ evaluates child behaviour over the last six months and consists of 5 subscales; 
emotional problems, conduct problems, hyperactivity/inattention, peer problems and prosocial 
behaviour. The questionnaire also contains an impact supplement, which includes questions 
evaluating whether the respondent thinks the child has a problem, and if so, inquires further 
about chronicity, distress, social impairment and burden to others. Both parents and teachers 
of the children were asked to complete the SDQ questionnaire and the impact supplement. In 
accordance with international recommendations we combined teacher and parent SDQ 
assessments(34), and we used the result from one respondent in cases where only one was 
available. Using a computerized algorithm for predicting disorders from multi-informant SDQ 
and impact scores, children were classified into three categories: “unlikely”, “possible” or 
“probable” for emotional disorder, conduct disorder and hyperactivity disorder.(38, 39) We 
subsequently dichotomized each scale into “possible/probable” versus “unlikely, as has been 
done by others investigating the relationship between AD and child behaviour using the 
SDQ.(29) For the SDQ subscales on peer problems and prosocial behaviour, algorithms for 
disorder prediction are not available, so we dichotomized these outcomes, with the 15% 






Logistic regression with calculation of robust standard errors using the “vce”-cluster 
command in STATA was used to assess associations of infantile AD, severe infantile AD, 
asthma symptoms, severe asthma and AD symptoms in the prior year at 6.5 years (the 
exposures) with the behaviour outcomes. We present results for: (1) a univariable cluster-
adjusted model; (2) a simple cluster- and sex-adjusted model; and (3) a fully-adjusted model, 
including trial arm and covariables selected based on current knowledge about the causes of 
the exposures and outcomes and previously published evidence of factors associated with the 
exposures and outcomes:  maternal age at delivery, trial arm, exclusive breastfeeding≥3 
months, birth weight (weight-for-length z-score at birth), maternal and paternal occupation 
(non-manual, manual, unemployed and unknown), parental alcohol consumption at 6.5 years 
(one or two parents with weekly or more frequent heavy drinking, one or two parents with 
weekly or more frequent moderate drinking and two parents with light or infrequent 
drinking),(40) maternal and paternal education (completed university, advanced secondary or 
partial university, common secondary and incomplete secondary or unknown), parental 
allergy (asthma, AD and/or hay fever present in mother and/or father at enrolment) and family 
situation at 6.5 years (stable two-parent family since birth, new two parent family and single 
parent). Revision of the covariates showed that sex was a confounder for many of the 
associations and we therefore present a sex and cluster-adjusted model. Otherwise, there was 
limited confounding. The addition of maternal education to the models increased the OR for 
the association between AD at 6.5 years with peer problems at 6.5 years by 6 %, ORs; 0.92; 
95% CI, 0.60-1.43 and 0.98; 95% CI, 0.62-1.53, respectively. Otherwise, included covariates 
did not impact risk estimates in the range outside +/- 5% for the exposures infantile AD or 
AD and asthma at 6.5 years. Participants with complete information on exposures, outcomes 




same study population including 11,668 individuals were used in all models. We compared 
these with those who were not included using chi-2 tests and found no significant differences 
regarding main exposures and outcomes, all p>0.19. Previous studies indicate that AD might 
be a confounder for the association between asthma and behaviour.(23) In models where 
asthma symptoms were the predictor, we therefore adjusted for concomitant and infantile AD. 
We fitted interaction terms to test whether the associations differed by sex, but sex did not 
modify the association between AD or asthma and child behaviour (all interaction p values 
>0.06) and so we present all results for both sexes combined. To evaluate whether another 
dichotomization of behaviour outcomes affected our results we performed sensitivity analyses 
for all AD and asthma exposures calculating ORs for ‘probable’ as compared to’ unlikely’ 
behavioural problems for the outcomes emotional disorder, conduct disorder and 
hyperactivity disorder. In addition, stratified analyses for children with and without any 
positive SPT and symptoms of AD and asthma at 6.5 years were undertaken. All statistical 
analyses were performed with STATA Statistical Software (release 14.2; Stata-Corp, College 







Study population and follow-up  
Fig 1 shows the flow of the study population from recruitment. For the current study, children 
with data available for either parent or teacher SDQ and complete data for AD,  asthma and 
for covariables used in the fully adjusted model were included (n=11,668). Characteristics for 
included children and the original cohort were similar with the exception of family situation, 
Table I. Missing data was more common for children with separated parents and since 
complete data was required for inclusion more children in the study population compared to 
the original cohort lived in stable two-parent families since birth.  SDQ assessments from just 
teacher, just parent and both teacher and parent were available for 27, 1,561 and 10,080 
participants, respectively. In Belarus children start school at 6 years of age and most missing 
teacher-completed SDQ forms were because the child had not yet started regular school.  
AD, asthma, SPT and behaviour problems in the study population 
The prevalence of AD decreased from 5.0% in infancy to 1.3% at 6.5 years (Table II). 
Wheeze in the past year was reported for 3.0%, and severe asthma symptoms for 0.7%, of 
children at 6.5 years. Of the 9,388 children who had SPTs, 22.6% had at least one positive 
result. The corresponding proportions among children with AD symptoms, asthma symptoms 
or severe asthma symptoms in the previous year were 35.7%, 49.5% and 66.1% respectively. 
Table II shows the number of girls and boys classified as having ‘probable’, ‘possible’ and 
‘unlikely’ problems based on the SDQ disease prediction for the behaviour outcomes 
hyperactivity/inattention, emotional and conduct problems. Corresponding numbers for the 
SDQ-scales peer problems and prosocial behaviour as well as cut-offs used for 
dichotomisation are also shown in Table II.  




AD in infancy was not associated with ‘possible/probable’ hyperactivity/inattention disorder 
(fully-adjusted OR, 0.91; 95% CI, 0.77 - 1.08), emotional disorder (fully-adjusted OR, 1.04; 
95% CI, 0.86 - 1.25) or conduct disorder (fully-adjusted OR, 1.12; 95% CI, 0.95 - 1.31). 
However, severe AD (versus no AD) in infancy was associated with lower odds for 
possible/probable hyperactivity/inattention disorder (fully-adjusted OR, 0.65; 95% CI, 0.44 - 
0.98) at 6.5 years (Table III). We excluded children with possible behaviour disorder in a 
sensitivity analysis and evaluated ORs for ‘probable’ behaviour versus ‘unlikely’ behaviour 
problems. In the sensitivity analysis, the negative association for severe infantile AD with 
probable hyperactivity/inattention was non-significant. However, in the sensitivity analysis 
infantile AD was associated with lower odds for probable hyperactivity/inattention (fully-
adjusted OR, 0.72; 95% CI, 0.53-0.99) at 6.5 years (Table E1). 
 Infantile AD was not associated with peer problems (fully-adjusted OR, 0.87; 95% CI, 0.70 - 
1.08) or prosocial behaviour (fully-adjusted OR, 1.01; 95% CI, 0.82 - 1.26) at 6.5 years, 
(Table III).   
AD and asthma symptoms in the past year at 6.5 years in relation to child behaviour at 
6.5 years  
We also evaluated the associations of the following questionnaire-derived binary ISAAC 
exposures in the past year: AD symptoms, persistent AD symptoms, sleep-disturbed AD 
symptoms, asthma symptoms and severe asthma symptoms with child behaviour at 6.5 years. 
We found a higher odds of ‘possible/probable’ emotional disorder at 6.5 years among children 
with AD symptoms in the previous year (fully-adjusted OR, 2.24, 95% CI 1.62-3.12), 
persistent AD in the previous year (fully-adjusted OR, 2.69; 95% CI, 1.38 - 5.22), wheeze in 
the previous year (fully-adjusted OR, 1.45; 95% CI, 1.07 - 1.96) and severe asthma symptoms 




estimate for possible/probable emotional disorder for the exposure asthma in the previous 
year without adjustment for AD in past year was similar (fully-adjusted OR, 1.51; 95% CI, 
1.11 - 2.04). In a sensitivity analysis, we excluded children with ‘possible’ behaviour disorder 
and computed ORs for ‘probable’ versus ‘unlikely’ disorder. The risk estimates for ‘probable’ 
emotional disorder were similar but significant associations were only found for AD 
symptoms and persistent AD symptoms in the past year (Table E2). However, in the 
sensitivity analysis AD symptoms in the past year were significantly associated with 
‘probable’ hyperactivity/inattention disorder (fully-adjusted OR, 2.05; 95% CI, 1.09-3.84). 
Also, severe asthma symptoms past year tended to be positively associated with probable 
hyperactivity/inattention but the association was non-significant in the fully-adjusted model 
(fully-adjusted OR, 1.93; 95% CI, 0.91 – 4.09). Out of children with AD at 6.5 years, 36 
children also had AD in infancy. We evaluated the effects of AD at both time points using 
children with no history of AD at either time point as the reference and found an OR for 
emotional problems of 3.06 (95% CI 1.74- 5.37), but no other significant associations. AD or 
asthma symptoms in the previous year were not associated with any of the child behaviour 
outcomes: conduct problems, peer problems or prosocial behaviour at 6.5 years. We also 
assessed whether the SPT results affected child behaviour among children with AD and 
asthma (including severe phenotypes) the previous year, but effect sizes were similar for 







Physician-diagnosed AD during the first year of life did not increase the odds of behavioural 
problems at 6.5 years. However, at 6.5 years, emotional problems were more common among 
children with AD and with asthma symptoms in the past year. In addition, children with AD 
symptoms in the past year had increased odds for ‘probable’ hyperactivity/inattention disorder 
at 6.5 years. There was little evidence of important associations with other behaviours.  
The strengths of our study include its prospective design, with collection of background data 
and repeated follow-up visits during the first year of life, thus reducing the risk of recall bias. 
We also adjusted for concomitant AD and AD recorded during the first year of life when 
exploring the association between asthma symptoms and behaviour. This is important, since 
positive associations between wheeze or asthma and ADHD might be explained by previous 
or concomitant AD(23), although this approach might infer overadjustment. Our large sample 
size and wide geographical spread in Belarus are additional strengths. Physician skin 
examination for AD during the first year of life and skin prick testing for several inhalant 
allergens at 6.5 years are also major strengths. Finally, behaviour assessments were made by 
both parent and teacher for most children. This is important since parental and teachers’ SDQ 
assessment have been demonstrated to be complementary showing different informants 
sensitive to different domains of behaviours(38) and the SDQ prediction has been shown to 
work best when SDQs have been completed by both parents and teachers.(41)  
Limitations of our study include that child behaviour was measured at one time point only and 
at an age (6.5 years) when behavioural problems might not be fully developed. We can also 
not fully exclude the possibility that behavioural problems might have preceded asthma and 
AD in some children. Another limitation is that we did not have information regarding 
parental psychopathology and therefore could not adjust for this possible confounder.  Food 




children have a more severe phenotype.(42) A recent study found an association between 
maternally reported emotional problems and food allergy among teenagers and young 
adults.(43) Sensitization to foods was not assessed in our study, however, food allergies are 
rare in Belarus, and severe AD was very uncommon in our study population (0.4%).  
Nevertheless, we cannot fully rule out that food allergies contributed to emotional problems in 
some study children with AD.  We performed multiple testing which increase the risk for type 
1 errors. We evaluate three independent exposures and five independent outcomes and if we 
had used a Bonferroni correction, a p-value of 0.003 had been considered significant and the 
only significant association had been the association between AD the past year and emotional 
problems at 6.5 years.  However, our main findings regarding the association between asthma 
and AD symptoms the past year with emotional problems are consistent and risk estimates are 
higher for more severe disease. Thus, we do not believe that type 1 errors explain our 
findings. 
In a German birth cohort study including 770 children from the general population, 
information on AD before age 4 years was obtained by questionnaires to parents and 
physicians. AD was strongly associated with parental reports of doctor-diagnosed ADHD or 
ADHD medication up to age 8 years (adjusted relative risk, 5.17; 95% CI, 2.18 -12.3).(28) 
Another German birth cohort study including 2,916 individuals evaluated with parental SDQ 
at age 10 years found that children with parental reports of AD during infancy had an 
increased risk of emotional symptoms (adjusted OR, 1.62; 95% CI, 1.25 - 2.09) and AD 
limited to infancy was associated with conduct problems (adjusted OR, 1.75; 95% CI, 1.18 - 
2.60).(29) These studies found that AD early in life increases the risk for ADHD. The 
findings are in line with the theory of a neuro-immunologic pathway and the important 
question whether targeted preventive measures for infants with AD could reduce behavioural 




questionnaires,(28-31) we used clinical examinations by a physician at several follow-up 
visits during the first year of life to evaluate AD in infancy. The only significant association 
with behaviour was a reduced odds of hyperactivity/inattention at 6.5 years. This finding is 
difficult to explain clinically and might be due to chance, since multiple hypotheses were 
tested.  Thus, our results do not confirm previous findings of higher risk of behavioural 
problems among children with AD in infancy. 
Most studies regarding atopic diseases and child behaviour have investigated the association 
with ADHD, rather than other forms of altered child behaviour, and positive associations have 
been found both for asthma and AD.(44) In line with previous research we found a significant 
association between AD symptoms and ‘probable’ hyperactivity/inattention disorder. In 
general, risk estimates were higher in the sensitivity analysis evaluating ORs for ‘probable’ 
hyperactivity/inattention disorder as compared to ORs for ‘possible/probable’ 
hyperactivity/inattention disorder. However, no other significant associations for 
hyperactivity/inattention disorder were detected.   In contrast, risk estimates for ‘probable’ 
emotional disorder in the sensitivity analysis were similar to risk estimates for 
‘possible/probable’ emotional disorder.  A recent meta-analysis (n=188,495) showed that AD 
among adults and adolescents is associated with increased risk for depression (pooled RR, 
2.02; 95% CI, 1.76-2.31).(45) Our study indicates that emotional problems among individuals 
with AD and asthma start already in childhood. We found positive associations of 
concurrently assessed AD and asthma symptoms during the past year with emotional 
problems at 6.5 years, with the highest odds of emotional problems observed in children with 
persistent AD symptoms in the previous year, probably representing more severe disease. 
Schmitt et al, also found an increased risk of emotional problems at 10 years (adjusted OR, 
1.74; 95% CI, 1.29 - 2.35) among children with AD at 3-10 years.(29) In contrast, a cross-




and emotional problems among children (adjusted OR, 1.29; 95% CI, 0.98 - 1.71).(46) In the 
same study, however, current asthma was associated with emotional problems (adjusted OR, 
1.83; 95% CI, 1.44 - 2.33), which is similar to our findings. 
In summary, we found no evidence of a positive association between physician-diagnosed AD 
in infancy with behavioural problems later in childhood. Thus, in relation to previously 
suggested potential pathways for the associations between allergic diseases and behavioural 
problems our findings do not support the theory of a neuro-immunologic pathway or shared 
genetic vulnerability. Nor did we find evidence that sleep disturbance among children with 
AD added to the risk for behavioural problems. In conclusion, recent AD seems to be 
associated with increased odds for ‘probable’ hyperactivity/inattention disorder and both 
asthma and AD symptoms, especially when persistent and severe, were associated with an 
increased odds of concomitant emotional problems already at 6.5 years of age. Based on our 
findings we think that physicians taking care of children with AD and asthma, especially 
when severe, should consider screening for emotional problems. 
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Study population  
n= 11,668 
Characteristic n % n % 
Measured at child’s birth      
Maternal age, y      
  <20 2,394 14.1 1,471 12.6 
  20-34 13,931 81.7 9,705 83.2 
  ≥35 720 4.2 492 4.2 
Maternal education     
  Completed university 2,316 13.6 1,637 14.0 
  Advanced secondary or partial university 8,570 50.3 6,032 51.7 
  Common secondary 5,497 32.2 3,632 31.1 
  Incomplete secondary or unknown  663 3.9 367 3.2 
Paternal education     
  Completed university 2,292 13.4 1,561 13.4 
  Advanced secondary or partial university 7,689 45.1 5,488 47.0 
  Common secondary 6,080 35.7 4,326 37.1 
  Incomplete secondary or unknown  985 5.8 293 2.5 
Maternal occupation     
  Non-manual 7,239 42.5 5,257 45.1 
  Manual 5,634 33.0 3,931 33.7 
  Unemployed 4,173 24.5 2,480 21.2 
Paternal occupation     
  Non-manual 4,855 28.5 3,431 29.4 
  Manual 8,964 52.6 6,551 56.2 
  Unemployed 2,466 14.5 1,548 13.6 
  Unknown 761 4.5 138 1.2 
Parental allergy     
   No 15,949 96.7 11,315 97.0 
   Yes 548 3.3 353 3.0 
Intervention     
   No 8,181 48.0 5,759 49.4 
   Yes 8,865 52.0 5,909 50.6 
Child sex     




  Male 8,829 51.8 6,107 52.3 
 Mean SD Mean SD 
Birthweight,  mean (SD), kg 3.44 0.42 3.47 0.41 
Measured in child’s first year n % n % 
Exclusive breastfeeding ≥3 months     
   No 12,256 73.2 8,516 73.0 
   Yes 4,483 26.8 3,152 27.0 
Measured at 6.5 years  PROBIT  phase II     
Parental alcohol consumption     
  Heavy drinking 1,199 9.7 1,102 9.4 
  Moderate drinking 1,487 12.0 1,387 11.9 
  Light drinking 9,724 78.4 9,179 78.7 
Family situation     
  Stable two-parent since birth 11,289 82.6 10,642 91.2 
  New two-parent 675 4.9 347 3.0 






Table II.  AD, asthma (exposures) and behaviours (outcomes) for girls and boys in the study 
population (n=11,668) 
 Girls Boys Total 
 N % N % N % 
Age 0-1 year skin examinations       
 Infantile AD 230 4.1 347 5.7 577 5.0 
 Severe infantile AD*  47 0.9 68 1.2 115 1.0 
Age 6.5 years ISAAC questions       
  AD symptoms past year 74 1.3 82 1.3 156 1.3 
     Persistent AD symptoms past year 21 0.4 24 0.4 45 0.4 
  Sleep-disturbed AD symptoms past year 16 0.3 27 0.5 43 0.4 
     Asthma symptoms past year 140 2.5 211 3.5 351 3.0 
     Severe asthma symptoms past year 25 0.5 49 0.8 74 0.7 
Child behaviour at age 6.5 years according to  SDQ      
    Hyperactivity/inattention       
     Unlikely 4,675 84.1 4,439 72.7 9,114 78.1 
     Possible 752 13.5 1,333 21.8 2,085 17.9 
        Probable 134 2.4 335 5.5 469 4.02 
    Emotional problems       
     Unlikely 4,668 84.3 5,116 83.8 9,804 84.0 
     Possible/ Probable 470 8.5 611 10.0 1,081 9.3 
        Probable 403 7.2 380 6.2 783 6.7 
    Conduct problems       
     Unlikely 4,622 83.1 4,220 69.1 8,842 75.8 
     Possible 622 11.2 1,103 18.1 1,725 14.8 
        Probable 317 5.7 784 12.8 1,101 9.4 
   Peer problems**       
     Low (scale 0-3) 4,711 84.7 5,040 82.5 9,751 83.6 
     High (scale 4-10) 850 15.3 1,067 17.5 1,917 16.4 
   Prosocial behaviour**       
     High (scale 7-10) 5,015 90.2 4,874 79.8 9,889 84.7 
     Low (scale 0-6) 546 9.8 1,233 20.2 1,779 15.3 
* Subgroup within the group having infantile AD, including infants with persistent (AD present at two 
or more follow-up visits the first year of life) and widespread AD (AD affecting two or more body 
sites). 
**Teacher and parent SDQ scores were added and divided by two and for individuals with only one 




Table III. OR estimates calculated by logistic regression for child behaviour at 6.5 years (SDQ probable/possible versus unlikely) 
in relation to atopic dermatitis (AD) in infancy based on repeated skin examinations during the first year of life (n=11,668) 
Outcome○ 
Cluster-adjusted analysis Cluster & sex-adjusted 
analyses 
Fully-adjusted analysis□ 
   Exposure          
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value 
Hyperactivity/inattention          
   Atopic dermatitis in infancy 0.98 0.82 - 1.16 0.78 0.92 0.78 - 1.10 0.36 0.91 0.77 - 1.08 0.29 
   Severe AD in infancy* 0.71 0.48 - 1.03 0.07 0.67 0.46 - 0.97 0.03 0.65 0.44 - 0.98 0.04 
Emotional problems          
   Atopic dermatitis in infancy 1.14 0.94 - 1.37 0.18 1.13 0.94 - 1.37 0.19 1.04 0.86 - 1.25 0.68 
   Severe AD in infancy* 1.05 0.64 - 1.71 0.85 1.05 0.64 - 1.71 0.86 0.92 0.56 - 1.53 0.76 
Conduct problems          
   Atopic dermatitis in infancy 1.18 1.01 - 1.37 0.04 1.11 0.95 - 1.30 0.17 1.12 0.95 - 1.31 0.18 
   Severe AD in infancy* 0.92 0.61 - 1.40 0.70 0.87 0.58 - 1.30 0.50 0.89 0.59 - 1.33 0.57 
Peer problems          
   Atopic dermatitis in infancy 0.89 0.73 - 1.08 0.23 0.87 0.72 - 1.07 0.18 0.87 0.70 - 1.08 0.22 
   Severe AD in infancy* 1.13 0.73 - 1.74 0.58 1.12 0.72 - 1.73 0.61 1.17 0.73 - 1.86 0.52 
Prosocial behaviour          
   Atopic dermatitis in infancy 1.08 0.88 - 1.35 0.45 1.02 0.82- 1.27 0.87 1.01 0.82 - 1.26 0.90 
   Severe AD in infancy* 0.90 0.55 - 1.47 0.68 0.85 0.51 - 1.42 0.53 0.83 0.51 - 1.38 0.48 
□Adjusted for cluster, sex, trial arm, birth weight, maternal age, breastfeeding, maternal and paternal education, maternal and paternal occupation, parental 
allergy, parental alcohol consumption, family situation, asthma and AD symptoms past year at 6.5 years. 
○ SDQ disorder prediction was used comparing ‘probable/possible’ versus ‘unlikely’ for the outcomes hyperactivity/inattention, emotional problems and 
conduct problems. For the outcomes peer problems and prosocial behaviour a cut of including 15 percent of children assessed with most problems were 
compared to the others for each scale respectively.   
* Infants with persistent (AD present at two or more follow-up visits) and widespread AD (AD affecting two or more body sites) 
Reference group for all AD exposures were children with no infantile AD. 
Table IV. OR estimates calculated by logistic regression for child behaviour at 6.5 years in relation to AD and asthma in the past year 
(n=11,668) 
Outcome 






   Exposure          
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value 
Hyperactivity/inattention          
   AD symptoms in the past year 1.19 0.77 - 1.86 0.44 1.19 0.74 - 1.93 0.47 1.21 0.76 - 1.92 0.43 
   Persistent AD symptoms in the past year 0.89 0.32 - 2.51 0.83 0.89 0.31 - 2.53 0.82 0.95 0.34 - 2.65 0.92 
   Sleep-disturbed AD symptoms past year 1.38 0.66 - 2.90 0.39 1.30 0.59 - 2.84 0.51 1.27 0.57 - 2.80 0.56 
   Asthma symptoms past year 1.00 0.81 - 1.23 0.98 0.95 0.77 - 1.18 0.65 0.97 0.79 - 1.18 0.74 
   Severe asthma symptoms past year 1.23 0.77 - 1.97 0.38 1.13 0.70 - 1.82 0.63 1.12 0.69 - 1.81 0.65 
Emotional problems          
   AD symptoms in the past year 2.23 1.60 - 3.11 <0.001 2.23 1.59 - 3.12 <0.001 2.24 1.62- 3.12 <0.001 
   Persistent AD symptoms in the past year 2.67 1.36 - 5.20 0.004 2.67 1.37 - 5.20 0.004 2.69 1.38 - 5.22 0.004 
   Sleep-disturbed AD symptoms past year 1.83 0.88 - 3.83 0.11 1.82 0.87 - 3.83 0.11 1.69 0.81 - 3.55 0.16 
   Asthma symptoms past year 1.50 1.11 - 2.03 0.009 1.49 1.10 - 2.02 0.01 1.45 1.07 - 1.96 0.02 
   Severe asthma symptoms past year 2.11 1.26 - 3.55 0.005 2.10 1.25 - 3.55 0.005 1.93 1.13 - 3.32 0.02 
Conduct problems          
   AD symptoms in the past year 0.97 0.63 - 1.50 0.90 0.97 0.63 - 1.50 0.89 0.99 0.66 - 1.50 0.98 
   Persistent AD symptoms in the past year 1.27 0.72 - 2.25 0.41 1.27 0.70 - 2.30 0.43 1.34 0.78 - 2.31 0.29 
   Sleep-disturbed AD symptoms past year 0.61 0.29 - 1.27 0.19 0.56 0.26 - 1.18 0.13 0.57 0.27 - 1.21 0.14 
   Asthma symptoms past year 0.88 0.69 - 1.11 0.28 0.82 0.64 - 1.06 0.13 0.86 0.65 - 1.14 0.29 





Peer problems          
   AD symptoms in the past year 0.92 0.60 - 1.43 0.72 0.92 0.60 - 1.43 0.72 1.02 0.63 - 1.64 0.95 
   Persistent AD symptoms in the past year 1.64 0.85 - 3.17 0.14 1.64 0.85 - 3.17 0.14 1.97 0.99 - 3.91 0.05 
   Sleep-disturbed AD symptoms past year 0.38 0.13 - 1.15 0.09 0.37 0.12 - 1.13 0.08 0.42 0.14 - 1.22 0.11 
   Asthma symptoms past year 1.01 0.82 - 1.23 0.95 1.00 0.81 - 1.22 0.96 1.06 0.87 - 1.30 0.55 
   Severe asthma symptoms past year 1.29 0.78 - 2.16 0.32 1.27 0.75 - 2.14 0.37 1.45 0.85 - 2.47 0.17 
Prosocial behaviour          
   AD symptoms in the past year 0.91 0.57 - 1.45 0.69 0.91 0.58 - 1.43 0.68 0.94 0.57 - 1.54 0.80 
   Persistent AD symptoms in the past year 1.02 0.45 - 2.30 0.96 1.01 0.44 - 2.32 0.97 1.05 0.45 - 2.47 0.91 
   Sleep-disturbed AD symptoms past year 0.73 0.19 – 1.74 0.64 0.67 0.18 - 2.49 0.55 0.73 0.20 - 2.74 0.64 
   Asthma symptoms past year 0.99 0.72 - 1.36 0.94 0.93 0.66 - 1.29 0.66 0.97 0.69 - 1.38 0.88 
   Severe asthma symptoms past year 0.77 0.38 - 1.56 0.47 0.69 0.34 - 1.38 0.29 0.76 0.37 - 1.57 0.46 
□Adjusted for cluster, sex, trial arm, birth weight, maternal age, breastfeeding, maternal and paternal education, maternal and paternal occupation, parental 
allergy, parental alcohol consumption, family situation and AD in previous follow-ups. For AD outcomes adjustment was made for concomitant asthma 
symptoms and vice versa. Reference group for all AD exposures are children with no AD symptoms in past year and for asthma symptoms the reference group is 
children with no asthma symptoms in the past year. 
* SDQ disorder prediction was used comparing probable/possible versus unlikely for the outcomes hyperactivity/inattention, emotional problems 
and conduct problems. For the outcomes peer problems and prosocial behaviour a cut of including around 15 percent of children assessed with 










Supplementary Table 1. Sensitivity analysis  
OR estimates calculated by logistic regression for child behaviour (SDQ probable versus unlikely) at 6.5 years  
in relation to atopic dermatitis (AD) in infancy based on repeated skin examinations during the first year of life 
Outcome SDQ probable versus unlikely 
Cluster-adjusted analysis Cluster & sex-adjusted 
analyses 
Fully-adjusted analysis□ 
    Exposure          
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value 
Hyperactivity/inattention          
   Atopic dermatitis in infancy 0.85 0.62-1.18 0.33 0.79 0.58-1.08 0.13 0.72 0.53-0.99 0.04 
   Severe AD in infancy* 0.40 0.10-1.61 0.20 0.37 0.10-1.46 0.16 0.31 0.08-1.20 0.09 
Emotional problems          
   Atopic dermatitis in infancy 1.09 0.79-1.49 0.61 1.10 0.80-1.51 0.56 1.02 0.73-1.42 0.91 
   Severe AD in infancy* 0.92 0.47-1.78 0.80 0.93 0.48-1.80 0.82 0.82 0.42-1.63 0.58 
Conduct problems          
   Atopic dermatitis in infancy 0.95 0.70-1.29 0.76 0.89 0.65-1.22 0.47 0.87 0.63-1.20 0.40 
   Severe AD in infancy* 0.72 0.39-1.33 0.29 0.67 0.36-1.24 0.20 0.68 0.36-1.27 0.22 
□Adjusted for cluster, sex, trial arm, birth weight, maternal age, breastfeeding, maternal and paternal education, maternal and paternal occupation, parental 
allergy, parental alcohol consumption, family situation, asthma and AD symptoms past year at 6.5 years. 
* Infants with persistent (AD present at two or more follow-up visits) and widespread AD (AD affecting two or more body sites) 
Reference group for all AD exposures were children with no infantile AD. 
Supplementary Table 2. Sensitivity analysis   
OR estimates calculated by logistic regression for child behaviour (SDQ probable versus unlikely) at 6.5 years in relation to AD and asthma 
symptoms in the past year  
Outcome SDQ probable versus unlikely 
Cluster-adjusted analysis Cluster & sex-adjusted 
analyses 
Fully-adjusted analysis□ 
    Exposure          
 OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value 
Hyperactivity/inattention          
   AD symptoms in the past year 2.02 1.10-3.71 0.02 2.01 1.06-3.81 0.03 2.05 1.09-3.84 0.02 
   Persistent AD symptoms in the past year 2.19 0.66-7.20 0.20 2.11 0.65-6.81 0.21 2.39 0.72-7.98 0.16 




   Asthma symptoms past year 1.44 1.04-1.99 0.03 1.34 0.94-1.90 0.10 1.30 0.93-1.80 0.12 
   Severe asthma symptoms past year 2.50 1.30-4.82 0.006 2.19 1.09-4.39 0.03 1.93 0.91-4.09 0.09 
Emotional problems          
   AD symptoms in the past year 2.07 1.35-3.17 0.001 2.07 1.36-3.17 0.001 2.09 1.36-3.20 0.001 
   Persistent AD symptoms in the past year 2.53 1.18-5.43 0.02 2.54 1.19-5.41 0.02 2.61 1.19-5.70 0.02 
   Sleep-disturbed AD symptoms past year 1.58 0.56-4.50 0.39 1.60 0.56-4.60 0.38 1.51 0.54-4.23 0.43 
   Asthma symptoms past year 1.34 0.91-1.96 0.13 1.35 0.92-1.98 0.12 1.31 0.89-1.93 0.18 
   Severe asthma symptoms past year 1.91 1.00-3.65 0.05 1.96 1.02-3.77 0.04 1.83 0.93-3.60 0.08 
Conduct problems          
   AD symptoms in the past year 0.94 0.58-1.55 0.82 0.96 0.59-1.56 0.86 0.97 0.59-1.60 0.92 
   Persistent AD symptoms in the past year 1.50 0.66-3.44 0.33 1.57 0.66-3.71 0.31 1.84 0.81-4.16 0.14 
   Sleep-disturbed AD symptoms past year 0.22 0.03-1.66 0.14 0.21 0.03-1.57 0.13 0.21 0.03-1.58 0.13 
   Asthma symptoms past year 1.00 0.73-1.36 0.98 0.92 0.66-1.29 0.64 0.98 0.70-1.39 0.93 
   Severe asthma symptoms past year 0.54 0.20-1.41 0.21 0.47 0.17-1.29 0.14 0.50 0.17-1.43 0.20 
*Adjusted for cluster, sex, trial arm, birth weight, maternal age, breastfeeding, maternal and paternal education, maternal and paternal occupation, parental 
allergy, parental alcohol consumption, family situation and AD in previous follow-ups. For AD outcomes adjustment was made for concomitant asthma 
symptoms and vice versa. Reference group for all AD exposures are children with no AD symptoms in past year and for asthma symptoms the reference group is 







Figure 1. Flow of the current study 
 
